[{"indications": "Indications\u00a0monotherapy and adjunctive treatment of focal\r\nseizures and generalised seizures including tonic-clonic seizures;\r\nseizures associated with Lennox-Gastaut syndrome; monotherapy of typical\r\nabsence seizures in children; prevention of depressive episodes associated\r\nwith bipolar disorder", "name": "LAMOTRIGINE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "4 Central nervous system", "4.8 Antiepileptic drugs", "4.8.1 Control of the epilepsies", "Lamotrigine", "LAMOTRIGINE"], "cautions": "Cautions\u00a0closely monitor and consider withdrawal\r\nif rash, fever, or other signs of hypersensitivity syndrome develop; avoid abrupt withdrawal (taper off over 2 weeks or\r\nlonger) unless serious skin reaction occurs; myoclonic seizures (may be exacerbated); Parkinson\u2019s disease (may be exacerbated); interactions: see Interactions in section 4.8.1 and Appendix 1 (lamotrigine)Blood disorders\u00a0Patients and their\r\ncarers should be alert for symptoms and signs suggestive of bone-marrow\r\nfailure, such as anaemia, bruising, or infection. Aplastic\r\nanaemia, bone-marrow depression, and pancytopenia have been associated\r\nrarely with lamotrigine", "side-effects": "Side-effects\u00a0nausea, vomiting, diarrhoea, dry mouth, aggression,\r\nagitation, headache, drowsiness, dizziness, tremor, insomnia, ataxia,\r\nback pain, arthralgia, nystagmus, diplopia, blurred vision, rash (see\r\nSkin Reactions, below); rarely conjunctivitis; very rarely hepatic failure, movement disorders, unsteadiness,\r\nincrease in seizure frequency, exacerbation of Parkinson\u2019s disease,\r\nconfusion, hallucination, blood disorders (including anaemia, leucopenia,\r\nthrombocytopenia, pancytopenia\u2014see Blood Disorders, above), hypersensitivity\r\nsyndrome (see Antiepileptic Hypersensitivity\r\nSyndrome),\r\nlupus erythematosus-like reactions; also reported suicidal ideation, aspectic meningitisSkin reactions\u00a0Serious skin reactions including\r\nStevens-Johnson syndrome and toxic epidermal necrolysis have developed\r\n(especially in children); most rashes occur in the first 8 weeks.\r\nRash is sometimes associated with hypersensitivity syndrome (see Side-effects,\r\nabove) and is more common in patients with history of allergy or rash\r\nfrom other antiepileptic drugs. Consider withdrawal if rash or signs\r\nof hypersensitivity syndrome develop. Factors associated\r\nwith increased risk of serious skin reactions include concomitant\r\nuse of valproate, initial lamotrigine dosing higher\r\nthan recommended, and more rapid dose escalation than recommended.Counselling\u00a0Warn patients to see\r\ntheir doctor immediately if rash or signs or symptoms of hypersensitivity\r\nsyndrome develop (see Antiepileptic Hypersensitivity\r\nSyndrome)", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/9833.htm", "doses": ["Do not confuse the different combinations\r\nor indications; see also notes above", "Dose titration should be repeated if restarting\r\nafter an interval of more than 5 days", "Monotherapy of seizures, adult and child over 12 years, initially\r\n25\u00a0mg once daily for 14 days, increased to 50\u00a0mg once daily for further\r\n14 days, then increased by max. 100\u00a0mg every 7\u201314 days; usual maintenance\r\n100\u2013200\u00a0mg daily in 1\u20132 divided doses (up to 500\u00a0mg daily has been\r\nrequired)", "Monotherapy of typical absence seizures, child 2\u201312 years see BNF for Children", "Adjunctive therapy of seizures with valproate, adult and child over 12 years, initially 25\u00a0mg on alternate days for 14 days then\r\n25\u00a0mg once daily for further 14 days, thereafter increased by max.\r\n50\u00a0mg every 7\u201314 days; usual maintenance, 100\u2013200\u00a0mg daily in 1\u20132\r\ndivided doses; child 2\u201312 years initially\r\n150\u00a0micrograms/kg once daily for 14 days (those weighing under 13\u00a0kg\r\nmay receive 2\u00a0mg on alternate days for first 14 days) then 300\u00a0micrograms/kg\r\nonce daily for further 14 days, thereafter increased by max. 300\u00a0micrograms/kg\r\nevery 7\u201314 days; usual maintenance 1\u20135\u00a0mg/kg daily in 1\u20132 divided\r\ndoses; max. 200\u00a0mg daily", "Adjunctive therapy of seizures (with enzyme inducing drugs) without valproate, adult and child over 12 years, initially 50\u00a0mg once daily for\r\n14 days then 50\u00a0mg twice daily for further 14 days, thereafter increased\r\nby max. 100\u00a0mg every 7\u201314 days; usual maintenance 200\u2013400\u00a0mg daily\r\nin 2 divided doses (up to 700\u00a0mg daily has been required); child 2\u201312 years initially 600\u00a0micrograms/kg daily\r\nin 2 divided doses for 14 days then 1.2\u00a0mg/kg daily in 2 divided doses\r\nfor further 14 days, thereafter increased by max. 1.2\u00a0mg/kg every\r\n7\u201314 days; usual maintenance 5\u201315\u00a0mg/kg daily in 1\u20132 divided doses;\r\nmax. 400\u00a0mg daily", "Adjunctive therapy of seizures (without enzyme inducing drugs) without valproate, adult and child over 12 years, initially 25\u00a0mg once daily for\r\n14 days, increased to 50\u00a0mg once daily for further 14 days, then increased\r\nby max. 100\u00a0mg every 7\u201314 days; usual maintenance 100\u2013200\u00a0mg daily\r\nin 1\u20132 divided doses; child 2\u201312 years\r\ninitially 300\u00a0micrograms/kg daily in 1\u20132 divided doses for 14 days\r\nthen 600\u00a0micrograms/kg daily in 1\u20132 divided doses for further 14 days,\r\nthereafter increased by max. 600\u00a0micrograms/kg every 7\u201314 days; usual\r\nmaintenance 1\u201310\u00a0mg/kg daily in 1\u20132 divided doses; max. 200\u00a0mg daily", "Monotherapy or adjunctive therapy of bipolar\r\ndisorder (without enzyme inducing drugs) without valproate, adult over 18 years, initially 25\u00a0mg\r\nonce daily for 14 days, then 50\u00a0mg daily in 1\u20132 divided doses for\r\nfurther 14 days, then 100\u00a0mg daily in 1\u20132 divided doses for further\r\n7 days; usual maintenance 200\u00a0mg daily in 1\u20132 divided doses; max.\r\n400\u00a0mg daily", "Adjunctive therapy of bipolar disorder with valproate, adult over 18 years, initially 25\u00a0mg\r\non alternate days for 14 days, then 25\u00a0mg once daily for further 14\r\ndays, then 50\u00a0mg daily in 1\u20132 divided doses for further 7 days; usual\r\nmaintenance 100\u00a0mg daily in 1\u20132 divided doses; max. 200\u00a0mg daily", "Adjunctive therapy of bipolar disorder (with enzyme inducing\r\ndrugs) without valproate, adult over 18 years, initially 50\u00a0mg once daily for 14 days, then 50\u00a0mg\r\ntwice daily for further 14 days, then 100\u00a0mg twice daily for further\r\n7 days, then 150\u00a0mg twice daily for further 7 days; usual maintenance\r\n200\u00a0mg twice daily", "Patients stabilised on lamotrigine for bipolar\r\ndisorder may require dose adjustments if other drugs are added to\r\nor withdrawn from their treatment regimens\u2014consult product literature"], "pregnancy": "Pregnancy\u00a0see Pregnancy"}]